Abingdon Health (LON:ABDX) Issues Quarterly Earnings Results

Abingdon Health (LON:ABDX – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Stock Performance

Abingdon Health stock opened at GBX 8.87 on Thursday. The firm has a market capitalization of £22.41 million, a PE ratio of -10.94 and a beta of 0.13. Abingdon Health has a one year low of GBX 5.50 and a one year high of GBX 13. The stock’s 50 day moving average price is GBX 10.70 and its 200 day moving average price is GBX 10.53. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91.

Get Abingdon Health alerts:

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.

Featured Articles

• Five stocks we like better than Abingdon Health
• Mortgage Rates Squeeze FHA Buyers: 3 Housing Stocks to Watch
• UnitedHealth Beats on Earnings, But Investors Question Growth Path
• Swarm Economics: Can XTEND AI Robotics Deliver at Scale?
• Tesla Wants to Make Its Own Chips—What Could Go Wrong?

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.